Table 5 Lifetime costs (US$), effectiveness and ICERs of ART compared to No-ART
Treatment option | Lifetime costs (95%CI) | Outcomes | ICER† | ||
|---|---|---|---|---|---|
Life Years (95%CI) | QALYs (95%CI) | Life Years (95%CI) | QALYs (95%CI) | ||
Undiscounted | |||||
No-ART | 2,966 (2,611–3,343) | 2.9 (2.6–3.3) | 2.1 (1.8–2.3) | ||
ART | 13,191 (11,167–16,056) | 12.9 (11.1–15.2) | 10.8 (9.1–12.5) | 1,023 (958–1,116) | 1,166 (1,092–1,279) |
Discounted | |||||
No-ART | 2,743 (2,414–3,057) | 2.7 (2.4–3.0) | 1.9 (1.7–2.1) | ||
ART | 9,435 (8,414–10,891) | 9.5 (8.5–10.7) | 8.0 (7.3–8.6) | 984 (913–1,078) | 1,102 (1,043–1,210) |